Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02709083
Title Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

chronic myeloid leukemia

Therapies

Dasatinib

Nilotinib

Imatinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory University/Winship Cancer Institute Atlanta Georgia 30322 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field